Literature DB >> 8482278

Cytokines predict coronary aneurysm formation in Kawasaki disease patients.

C Y Lin1, C C Lin, B Hwang, B N Chiang.   

Abstract

In this study, we measured serially the serum levels of cytokines including interleukin-6 (IL-6), IL-8, soluble IL-2 receptor (sIL-2R) and tumour necrosis factor alpha (TNF-alpha) in 60 patients with Kawasaki disease (KD) and evaluated the clinical significance of these cytokines in predicting coronary aneurysm formation. Of the 60 patients, 12 were complicated with coronary aneurysm. Blood samples were collected within the 1st week after onset of fever, then once a week for the 1st month, and once a month for another 5 months. The serum levels of IL-6, IL-8, sIL-2R and TNF alpha were measured using an ELISA or RIA method. Our results show that the changes in serum IL-6 and IL-8 were faster than those of sIL-2R and TNF alpha. Within the 1st week, the serum levels of IL-6 and IL-8 were significantly higher in the patients with than in those without coronary aneurysm (P < 0.001). In addition, the serum levels of IL-6 and IL-8 obtained in the 1st week were highly correlated (P < 0.001) with those of C-reactive protein and erythrocyte sedimentation rate, and the serum levels of sIL-2R and TNF alpha were also increased at the 1st week reaching the highest level in the 2nd week. In the 2nd week, the serum levels of sIL-2R and TNF alpha were significantly higher in the patients with than in those without coronary aneurysm (P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482278     DOI: 10.1007/bf01956740

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

Review 1.  Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines.

Authors:  S D Wolpe; A Cerami
Journal:  FASEB J       Date:  1989-12       Impact factor: 5.191

Review 2.  Kawasaki syndrome: clinical features. Pathophysiology, etiology and therapy.

Authors:  M E Melish; R V Hicks
Journal:  J Rheumatol Suppl       Date:  1990-09

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

Review 4.  Cytokines as communication signals between leukocytes and endothelial cells.

Authors:  A Mantovani; E Dejana
Journal:  Immunol Today       Date:  1989-11

Review 5.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.

Authors:  M Baggiolini; A Walz; S L Kunkel
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

6.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Authors:  Y Ueno; N Takano; H Kanegane; T Yokoi; A Yachie; T Miyawaki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

Review 7.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

8.  The changes of interleukin-2, tumour necrotic factor and gamma-interferon production among patients with Kawasaki disease.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

9.  Serial immunologic studies in patients with mucocutaneous lymph node syndrome (Kawasaki disease).

Authors:  C Y Lin; B Hwang
Journal:  Ann Allergy       Date:  1987-10

10.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes.

Authors:  C G Larsen; A O Anderson; E Appella; J J Oppenheim; K Matsushima
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

View more
  18 in total

1.  Plasma follistatin-like protein 1 is elevated in Kawasaki disease and may predict coronary artery aneurysm formation.

Authors:  Mark Gorelik; David C Wilson; Yona K Cloonan; Stanford T Shulman; Raphael Hirsch
Journal:  J Pediatr       Date:  2012-02-07       Impact factor: 4.406

2.  The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.

Authors:  L Morgan; J Cooper; H Montgomery; N Kitchen; S E Humphries
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-28       Impact factor: 10.154

3.  Ventricular repolarization lability in children with Kawasaki disease.

Authors:  Marina Kuriki; Masayuki Fujino; Ken-ichi Tanaka; Kayo Horio; Hirofumi Kusuki; Misa Hosoi; Yoshihiko Eryu; Tomochika Kato; Toshio Yamazaki; Tadayoshi Hata
Journal:  Pediatr Cardiol       Date:  2011-02-23       Impact factor: 1.655

4.  Bifidobacterium plays a protective role in TNF-α-induced inflammatory response in Caco-2 cell through NF-κB and p38MAPK pathways.

Authors:  Nana Nie; Cui Bai; Shanai Song; Yanyan Zhang; Benzhen Wang; Zipu Li
Journal:  Mol Cell Biochem       Date:  2019-11-18       Impact factor: 3.396

5.  Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Agents Actions       Date:  1994-10

6.  Increased CD11b expression on polymorphonuclear leucocytes and cytokine profiles in patients with Kawasaki disease.

Authors:  T Kobayashi; H Kimura; Y Okada; Y Inoue; T Kobayashi; M Shinohara; A Morikawa
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

7.  Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.

Authors:  Masaru Miura; Kazuki Kohno; Hirotaka Ohki; Shigeki Yoshiba; Akinori Sugaya; Masaaki Satoh
Journal:  Eur J Pediatr       Date:  2008-01-04       Impact factor: 3.183

8.  Inflammation aggravates heterogeneity of ventricular repolarization in children with Kawasaki disease.

Authors:  Masayuki Fujino; Tadayoshi Hata; Marina Kuriki; Kayo Horio; Hidetoshi Uchida; Yoshihiko Eryu; Hiroko Boda; Masafumi Miyata; Tetsushi Yoshikawa
Journal:  Pediatr Cardiol       Date:  2014-05-14       Impact factor: 1.655

9.  QT Dispersion and T Wave Peak-to-end Interval Dispersion in Children with Kawasaki Disease.

Authors:  Hamid Amoozgar; Maryam Ahmadipour; Anis Amirhakimi
Journal:  Int Cardiovasc Res J       Date:  2013-09-01

10.  Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating amp-activated protein kinase (AMPK) signaling.

Authors:  Jian-Li Zhang; Ying Xu; Jie Shen
Journal:  Int J Mol Sci       Date:  2014-07-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.